Radcliff Department of Medicine scientists have achieved the most detailed view yet of how DNA folds and functions inside living cells, revealing the physical structures that control when and how genes are switched on.
Researchers from the Kennedy Institute are part of a UK-wide consortium that has been awarded a \u00a3644K BBSRC Network Grant to establish the Microbiome Innovation Network (Microbiome-Net).
The research will add to a growing body of evidence on the effects of probiotics on mood and cognition and their ability to positively affect menopausal symptoms.
The Nuffield Department of Surgical Sciences (NDS) hosted a special symposium on Friday 17 October 2025 in honour of Professor Tipu Aziz (1956\u20132024), Emeritus Professor of Neurosurgery and founder and head of Oxford Functional Neurosurgery.
Members of the Department of Physiology, Anatomy and Genetics (DPAG) are part of an international collaborative team that has published new research in Proceedings of the National Academy of Sciences.
Prof David Beard was the keynote speaker at a recent Surgical Trials Workshop in Ho Chi Minh City, Vietnam, contributing to improved treatment quality and greater international integration in healthcare and medical science.
A ground-breaking new study will test how artificial intelligence (AI) can make prostate cancer diagnosis more accurate. The study by the University of Oxford is funded by a \u00a31.9m grant from research charity Prostate Cancer UK.
OrganOx, a pioneering Oxford University spinout transforming kidney and liver transplantation, has been fully acquired by Terumo Corporation, a global medical technology company headquartered in Tokyo, Japan, for US$1.5 billion, marking the largest exit in Oxford University\u2019s spinout portfolio to date and the first in excess of \u00a31bn. The agreement for the acquisition was announced in August 2025.
A large new study led by researchers in the Nuffield Department of Primary Care Health Sciences has found that a common blood test used to help diagnose heart failure is less accurate in people who also have atrial fibrillation (AF).
A new multicentre trial to evaluate a minimally invasive treatment for patients with knee osteoarthritis could transform the way knee osteoarthritis is managed, potentially improving quality of life for patients long before surgery becomes necessary.
The University of Oxford has signed three landmark agreements with leading Vietnamese partners, deepening collaboration across healthcare, higher education and sustainable aviation.
NDS is celebrating the achievements of Professor Simon Buczacki and Dr Alex Gordon-Weeks, who have both received CRUK Discovery Programme Awards \u2014 a rare double success for a single university department.
Nuffield Department of Primary Care Health Science's researchers find government's soft drinks tax changes miss opportunity to maximise health benefits. Analysis shows targeting highest-sugar products could remove twice as much sugar from market as current proposals, particularly benefiting deprived areas.
A new study led by researchers at Oxford Population Health has found no significant differences in growth up to two years of age between children who were exposed to HIV during pregnancy but remained uninfected and those born to mothers without HIV. The study is published in eClinicalMedicine.
Members of the Department of Oncology attended ESMO earlier this month to present their research, chair sessions, and network with collaborators from across Europe and beyond. Read the highlights from our department\u2019s contributions to ESMO 2025.
A major nationwide study has revealed that the majority of bowel cancers diagnosed late, after a false-negative colonoscopy could have been prevented or detected earlier. The study is published in Endoscopy.
Michael - who is a CRUK Oxford Centre DPhil in Cancer Science student, working in the Nuffield Department of Medicine's Centre of Immuno-oncology - has been awarded the Best Poster Prize in CNS Tumours at the 2025 European Society for Medical Oncology (ESMO) Congress.
The Better Outcomes in Babies with Bacterial meningitis (BOBBi) trial will investigate whether giving steroids to babies with suspected bacterial meningitis means that more babies will survive without long-term difficulties.
Taking an innovative approach to clinical research in hip fracture, the World Hip Trauma Evaluation (WHiTE) Platform Trial has been launched to efficiently test multiple new treatments for patients with fractures of the hip.
![\"Detailed](\"https://www.medsci.ox.ac.uk/news/oxford-scientists-capture-genomes-structure-in-unprecedented-detail/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n